{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:33:05Z","timestamp":1783567985248,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1007\/bf03347703","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T11:28:14Z","timestamp":1396610894000},"page":"135-139","source":"Crossref","is-referenced-by-count":32,"title":["Long-term treatment of Nelson\u2019s syndrome by octreotide: A case report"],"prefix":"10.1007","volume":"17","author":[{"given":"L.","family":"Petrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gasperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pilosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347703_CR1","volume-title":"Endocrinology and Metabolism","author":"J D Baxter","year":"1987","unstructured":"Baxter J. D., Tyrrell J.B. The adrenal cortex. In: Felig P., Baxter J.D., Frohman L.A. (Eds.), Endocrinology and Metabolism, ed 2. McGraw-Hill, New York, 1987, p. 511.","edition":"2"},{"key":"BF03347703_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM195807242590403","volume":"259","author":"DH Nelson","year":"1958","unstructured":"Nelson D.H., Meakin J.W., Dealy J.B., Matson D.D., Kendall E., Thorn G.W. ACTH-producing tumor of the pituitary gland. N. Engl. J. Med. 259: 161, 1958.","journal-title":"N. Engl. J. Med."},{"key":"BF03347703_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-52-3-560","volume":"52","author":"DH Nelson","year":"1960","unstructured":"Nelson D.H., Meakin J.W., Thorn G.W. ACTH producing pituitary tumors following adrenalectomy for Cushing\u2019s syndrome. Ann. Intern. Med. 52: 560, 1960.","journal-title":"Ann. Intern. Med."},{"key":"BF03347703_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1227\/00006123-199012000-00016","volume":"27","author":"M Buchfelder","year":"1990","unstructured":"Buchfelder M., Fahlbusch R., Thierauf P., Muller O.A. Observations on the pathophysiology of Nelson\u2019s syndrome: a report of three cases. Neurosurgery 27: 961, 1990.","journal-title":"Neurosurgery"},{"key":"BF03347703_CR5","first-page":"363","volume":"11","author":"JDN Nabarro","year":"1977","unstructured":"Nabarro J.D.N. ACTH secreting pituitary tumors. J.R. Coll. Physicians Lond 11: 363, 1977.","journal-title":"J.R. Coll. Physicians Lond"},{"key":"BF03347703_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03348130","volume":"10","author":"I Halperin","year":"1987","unstructured":"Halperin I., Rodriguez M.D., Cardenal C., Casamitjana R., Martinez Osaba M.J., Lienas V., Vilardell E. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine. J. Endocrinol. Invest. 10: 77, 1987.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03347703_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/acta.0.1190435","volume":"119","author":"P Loli","year":"1988","unstructured":"Loli P., Berselli M.E., Vignati F., De Grandi C., Tagliaferri M. Size reduction of an ACTH-secreting pituitary macroadenoma in Nelson\u2019s syndrome by sodium valproate: effect of withdrawal and re-institution of treatment. Acta Endocrinol. (Copenh.) 119: 435, 1988.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03347703_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.1988.tb03656.x","volume":"28","author":"W Kelly","year":"1988","unstructured":"Kelly W., Adams J.E., Laing I., Longson D., Davies D. Long term treatment of Nelson\u2019s syndrome with sodium valproate. Clin. Endocrinol. (Oxf.) 28: 195, 1988.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347703_CR9","first-page":"9","volume":"30","author":"A Kasperik-Zaluska","year":"1989","unstructured":"Kasperik-Zaluska A., Migdalska B., Jeske W., Drac-Kaniewska J., Wisniewska-Wozniak T. The effect of magnesium valproate on plasma ACTH concentration in Nelson\u2019s syndrome. Acta Med. Pol. 30: 9, 1989.","journal-title":"Acta Med. Pol."},{"key":"BF03347703_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01468882","volume":"54","author":"HL Fehm","year":"1976","unstructured":"Fehm H.L., Voigt K.H., Lang R., Beinert K.E., Raptis S., Pfeifer E.F. Sandostatin, a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Clin. Wochenschr. 54: 173, 1976.","journal-title":"Clin. Wochenschr."},{"key":"BF03347703_CR11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-40-6-1125","volume":"40","author":"JB Tyrrell","year":"1975","unstructured":"Tyrrell J.B., Lorenzi M., Gerich J.E., Forsham P.H. Inhibition by somatostatin of ACTH secretion in Nelson\u2019s syndrome. J. Clin. Endocrinol. Metab. 40: 1125, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347703_CR12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1530\/acta.0.1200760","volume":"120","author":"SWJ Lamberts","year":"1989","unstructured":"Lamberts S.W.J., Vitterlinde P., Klijn J.M.G. The effect of the long-acting somatostatin analogue SMS 201\u2013995 on ACTH secretion in Nelson\u2019s syndrome and Cushing\u2019s disease. Acta Endocrinol. (Copenh.) 120: 760, 1989.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03347703_CR13","first-page":"472","volume":"75","author":"C Gicquel","year":"1992","unstructured":"Gicquel C., Lebouc Y., Luton J.P. Girard F., Bertagna X. Monoclonality of corticotroph adenomas in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 75: 472, 1992.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl2","key":"BF03347703_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0026-0495(92)90032-6","volume":"41","author":"A Warnet","year":"1992","unstructured":"Warnet A. The role of octreotide (Sandostatin) in non-Growth Hormone-, nonThyroid-Stimulating Hormone-, and non-Prolactin-Secreting Adenomas. Metabolism 41(Suppl 2): 59, 1992.","journal-title":"Metabolism"},{"issue":"Suppl2","key":"BF03347703_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0026-0495(92)90040-H","volume":"41","author":"K Werder Von","year":"1992","unstructured":"Von Werder K., Faglia G. Potential indications for octreotide in endocrinology. Metabolism 41(Suppl 2): 91, 1992.","journal-title":"Metabolism"},{"key":"BF03347703_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1990.tb00867.x","volume":"32","author":"C Invitti","year":"1990","unstructured":"Invitti C., De Martin M., Brunani A., Piolini M., Cavagnini F. Treatment of Cushing\u2019s syndrome with the long-acting somatostatin analogue SMS 201\u2013995 (Sandostatin). Clin. Endocrinol. (Oxf.) 32: 275, 1990.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347703_CR17","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1210\/endo-118-6-2188","volume":"118","author":"SWJ Lamberts","year":"1986","unstructured":"Lamberts S.W.J., Reubi J.C., Vitterlinden P., Zuiderwijsk J., Van Der Werp P., Van Hal P. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201\u2013995 on the growth of the prolactin\/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology 118: 2188, 1986.","journal-title":"Endocrinology"},{"key":"BF03347703_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-14-4-443","volume":"14","author":"JW Miller","year":"1993","unstructured":"Miller J.W., Crapo L. The medical treatment of Cushing\u2019s syndrome. Endocr. Rev. 14: 443, 1993.","journal-title":"Endocr. Rev."},{"key":"BF03347703_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03349555","volume":"13","author":"B Ambrosi","year":"1990","unstructured":"Ambrosi B., Bochicchio D., Fadin C., Faglia G. Failure of somatostatin and octreotide to acutely affect the hypothalamic pituitary-adrenal function in patients with corticotropin hypersecretion. J. Endocrinol. Invest. 13: 257, 1990.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03347703_CR20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/jcem-67-5-1080","volume":"67","author":"SWJ Lamberts","year":"1988","unstructured":"Lamberts S.W.J., Tilanus H.W., Kooswijk A.I.J., Bruining H.A., Van der Lely A.J., De Jong F.H. Successful treatment with SMS 201\u2013995 of Cushing\u2019s syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma. J. Clin. Endocrinol. Metab. 67: 1080, 1988.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347703_CR21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/jcem-68-5-988","volume":"68","author":"X Bertagna","year":"1989","unstructured":"Bertagna X., Favrod-Coune C., Escourolle H., Beuzeboc P., Christoforov B., Girard F., Luton J.P. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. J. Clin. Endocrinol. Metab. 68: 988, 1989.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347703_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01605073","volume":"419","author":"WA Reuss","year":"1991","unstructured":"Reuss W.A., Saeger W., Ludecke D.K. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing\u2019s disease and Nelson\u2019s syndrome. Virchows Arch. A. Pathol. Anat. Histopathol. 419: 395, 1991.","journal-title":"Virchows Arch. A. Pathol. Anat. Histopathol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347703\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:31:48Z","timestamp":1565332308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["BF03347703"],"URL":"https:\/\/doi.org\/10.1007\/bf03347703","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}